{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:58:06Z","timestamp":1763755086741,"version":"3.45.0"},"reference-count":0,"publisher":"Oncology Nursing Society (ONS)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1188\/19.cjon.212-216","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T08:23:06Z","timestamp":1552897386000},"source":"Crossref","is-referenced-by-count":0,"title":["Thrombopoietin Receptor Agonists: Eltrombopag and Romiplostim for the Treatment of Chronic Immune Thrombocytopenia Purpura"],"prefix":"10.1188","member":"1302","published-online":{"date-parts":[[2019,3,17]]},"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:50:56Z","timestamp":1763754656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/23\/2\/thrombopoietin-receptor-agonists-eltrombopag-and-romiplostim"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,17]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1188\/19.cjon.212-216","relation":{},"subject":[],"published":{"date-parts":[[2019,3,17]]}}}